← All indications
Gonadal Disorders
Pathological processes of the OVARIES or the TESTES.
Subtype terms (6)
More specific conditions that are subtypes of Gonadal Disorders in the MeSH hierarchy.
- Disorders of Sex Development
1 drug approved
- Hypogonadism
59 drugs (39 approved, 20 experimental)
- Ovarian Diseases
125 drugs (73 approved, 52 experimental)
- Puberty, Delayed
7 drugs (6 approved, 1 experimental)
- Puberty, Precocious
21 drugs (15 approved, 6 experimental)
- Testicular Diseases
12 drugs (11 approved, 1 experimental)
Drugs by status
Phase 4 trials (1)
Phase 2 trials (9)
Phase 1 trials (2)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 2 Indications (13)
- Merck KGaA
- Catalysis SL
- TesoRx Pharma, LLC
- North Florida Foundation for Research and Education
- National Cancer Institute (NCI)
- National Cancer Institute, Slovakia
- Nanjing Medical University
- Royan Institute
- University of Florida
- University of Copenhagen
- Department of Veteran Affairs
- Besins Healthcare
- Jiangsu Cancer Institute & Hospital
Organization Involved with Other Experimental Indications (4)